default image

Urologie

Information and services of the department

  • Number of inpatient cases: 636

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 206
Hyperplasia of prostate (N40) 189
Malignant neoplasm of prostate (C61) 60
Calculus of kidney and ureter - Calculus of ureter (N20.1) 52
Calculus of kidney and ureter - Calculus of kidney (N20.0) 24
Benign neoplasm of urinary organs - Benign neoplasm of bladder (D30.3) 10
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5) 8
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) 6
Obstructive and reflux uropathy (N13.3) 6
Calculus of kidney and ureter - Calculus of kidney with calculus of ureter (N20.2) 6
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 502
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 232
Surgical removal or destruction of prostatic tissue through the urethra (5-601.73) 124
Surgical removal or destruction of prostatic tissue through the urethra (5-601.72) 120
Insertion, exchange or removal of a ureteral stent (8-137.00) 85
Operation using lasers (5-985.9) 68
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.5) 54
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 48
Destruction of stones in the kidney and urinary tract by the external application of shock waves (8-110.2) 45
Insertion, exchange or removal of a ureteral stent (8-137.10) 28

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
8 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Gabriele Kachel

Prokuristin / Verwaltung

Phone: 07131 -156642-
Mail: ed.grebnehcrel-kinilk@gnutlawrev

Dr. med. Martin Soder

Geschäftsführer

Phone: 07131 -15660-
Mail: ed.grebnehcrel-kinilk@gnutlawrev